Search results for

Turmoil in the financial markets over the last few months has led to plunging share prices and boardroom unrest. With IP budgets under intense pressure, Stephen Mulrenan examines what practical steps brand owners can take to negotiate the credit crunch

If you are a big pharmaceutical company, spending millions of dollars to manage your intellectual property every year, you will want to find the best lawyers to advise you on prosecution and litigation matters. But as Susanne Sivborg, vice-president of global intellectual property at AstraZeneca, tells Stéphanie Bodoni, the most experienced lawyers are no good if they do not respond to her company's needs

David Barron and Alexandra Brodie examine how patent offices and the courts in Europe treat business method patents. They also compare European and US filing activity and ask whether European financial services companies are lagging behind their US counterparts

A monthly column devoted to IP curiosities and controversies, named in honour of John of Utynam – who received the world's first recorded patent in 1449

Managing IP held its first North America awards ceremony last month, with 150 people attending a black tie dinner at the Four Seasons Hotel in Georgetown Washington DC

Stéphanie Bodoni, Cannes

The US patent law is about to undergo a major change with a raft of reforms set to be implemented. These changes are considered to be the most comprehensive since Congress passed the 1952 patent Act. But, the path has not been smooth, with voices of dissent materializing as the government carves out its plans. MIP and Oblon, Spivak, McClelland, Maier & Neustadt jointly hosted a roundtable discussion – at a real roundtable – in Washington DC in late summer, to discuss some of those concerns and what really needs to be done

The month in words

The most sophisticated finance companies are now using IP as a growth driver. Managing IP provides an IP guide for banks

The CSU v Xerox case focused the antitrust bar's attention on the Federal Circuit and the fact that it was creating antitrust policy, albeit under the umbrella of patent law